Latest Paxman News & Updates
See the latest news and media coverage for Paxman. We track all announcements, press releases, and industry mentions in real time, all in one place.
World leader in scalp cooling technology
paxman.se- Headquarters
- Houston, United States
- Founded year
- 1996
- Company type
- Public company
- Number of employees
- 90–200
Last updated
Latest news about Paxman
In short: Paxman reported record 2025 growth, completed its merger with Dignitana, and secured legislative progress for U.S. scalp cooling insurance coverage.
Company announcements
-
Paxman supports AB 1682 for scalp cooling insurance coverage
The bill passed the Assembly Health Committee with bipartisan support and advances to Appropriations. Advocate Stella Serrao shared her positive experience.
-
Paxman reports growing momentum for scalp cooling insurance bills
West Virginia and Maryland passed bills effective January 2027. Advocates shared experiences on House and Senate floors.
-
Paxman shares key points from Scalp Cooling Registry
The largest study examines 7,424 patients in real-world settings. Data supports the Paxman Scalp Cooling Outcomes Calculator for clinicians.
-
Paxman publishes 2025 Annual Report
The report highlights US reimbursement progress, Dignitana acquisition, and innovation in scalp cooling and neuropathy programs. CEO calls it the biggest year yet.
Media coverage
-
'I am incredibly honoured' - Brighouse health innovation wins £100,000 to expand across hospitals
A Calderdale health innovation helping patients manage anxiety during high-stress medical treatments such as chemotherapy has won £100,000 in the Mayor's Big Ideas Challenge.
-
Paxman: Momentum Accelerates as 11 States Pursue Scalp Cooling Coverage Legislation in the U.S.
The MarketWatch News Department was not involved in the creation of this content. HOUSTON, March 12, 2026 /PRNewswire/ -- Building on statewide insurance mandates enacted...
-
Paxman AB: PAXMAN publishes year-end report as of 31 December 2025
Strategic investments support future growth! Figures in parentheses refer to the outcome for the corresponding period of the previous year.The Group's net sales amounted to...
-
Paxman AB: Paxman Announces Category III CPT Codes for Cryocompression Therapy to Prevent Chemotherapy-Induced Peripheral Neuropathy
Paxman, the global leader in cancer side effect management, today announced that the American Medical Association (AMA) CPT Editorial Panel has established three Category III...
Track Paxman and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Paxman competitors & trending companies
Browse news for competitors to Paxman and other trending companies.
Dignitana
Andon Labs
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze